Small Cap Stocks To Research – May 24th

Cerebras Systems, Akari Therapeutics, Destiny Tech100, Inflection Point Acquisition, and Inspira Technologies OXY B.H.N. are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small cap stocks are shares of companies with a relatively small market capitalization, typically between about $300 million and $2 billion, though exact thresholds can vary. For stock market investors, they often offer higher growth potential than larger companies, but they also tend to come with greater volatility and risk. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Cerebras Systems (CBRS)

We are building the fastest AI infrastructure in the world. In AI, speed is critical to win. Speed improves user engagement, expands product capabilities, can lower operating costs, and opens new markets. It shortens iteration cycles for engineers, researchers, and professionals across industries, allowing them to be more productive.

Akari Therapeutics (AKTX)

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid, as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration.

Destiny Tech100 (DXYZ)

Inflection Point Acquisition (IPAX)

Inspira Technologies OXY B.H.N. (IINN)

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.